JP7231307B2 - 抗微生物性テトラペプチド - Google Patents

抗微生物性テトラペプチド Download PDF

Info

Publication number
JP7231307B2
JP7231307B2 JP2020520812A JP2020520812A JP7231307B2 JP 7231307 B2 JP7231307 B2 JP 7231307B2 JP 2020520812 A JP2020520812 A JP 2020520812A JP 2020520812 A JP2020520812 A JP 2020520812A JP 7231307 B2 JP7231307 B2 JP 7231307B2
Authority
JP
Japan
Prior art keywords
alkyl group
compound
amino acid
group
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020520812A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021501133A5 (enExample
JP2021501133A (ja
Inventor
マルク ハイドル，
アイリーン ジャクソン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of JP2021501133A publication Critical patent/JP2021501133A/ja
Publication of JP2021501133A5 publication Critical patent/JP2021501133A5/ja
Application granted granted Critical
Publication of JP7231307B2 publication Critical patent/JP7231307B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2020520812A 2017-10-30 2018-10-29 抗微生物性テトラペプチド Active JP7231307B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17199080.7 2017-10-30
EP17199080 2017-10-30
PCT/EP2018/079522 WO2019086361A1 (en) 2017-10-30 2018-10-29 Antimicrobial tetrapeptides

Publications (3)

Publication Number Publication Date
JP2021501133A JP2021501133A (ja) 2021-01-14
JP2021501133A5 JP2021501133A5 (enExample) 2021-07-26
JP7231307B2 true JP7231307B2 (ja) 2023-03-01

Family

ID=60409114

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020520812A Active JP7231307B2 (ja) 2017-10-30 2018-10-29 抗微生物性テトラペプチド

Country Status (7)

Country Link
US (1) US20200308222A1 (enExample)
EP (1) EP3704134B1 (enExample)
JP (1) JP7231307B2 (enExample)
KR (1) KR102694657B1 (enExample)
CN (1) CN111278846B (enExample)
BR (1) BR112020008175A2 (enExample)
WO (1) WO2019086361A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025524352A (ja) * 2022-06-15 2025-07-30 ディーエスエム アイピー アセッツ ビー．ブイ． にきびの処置のためのｕｖフィルターの使用
WO2025174058A1 (ko) * 2024-02-15 2025-08-21 (주)뉴트리 탈모 유발 유해균에 대한 항균 효과를 갖는 두피 유래 펩타이드

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012158960A2 (en) 2011-05-17 2012-11-22 H. Lee Moffitt Cancer Center & Research Institute, Inc. Melanocortin 1 receptor ligands and methods of use
WO2014081845A2 (en) 2012-11-21 2014-05-30 University Of Cincinnati Skin care compositions and methods comprising selective agonists of melanocortin 1 receptor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466492A1 (en) 1979-10-03 1981-04-10 Elf Aquitaine Dyeing keratin substances, e.g. skin, nails, hair, fur - with compsns. contg. ketone or aldehyde dye and sulphoxy-aminoacid
FR2651126B1 (fr) 1989-08-29 1991-12-06 Oreal Association de dihydroxyacetone et de derives indoliques pour conferer a la peau une coloration similaire au bronzage naturel et procede de mise en óoeuvre.
FR2661673B1 (fr) 1990-05-07 1992-08-21 Oreal Association de dihydroxyacetone et de monohydroxyindoles pour conferer a la peau une coloration similaire au bronzage naturel, dispositif a plusieurs compartiments et procede de mise en óoeuvre.
DE19603018C2 (de) 1996-01-17 1998-02-26 Lancaster Group Gmbh Kosmetisches Selbstbräunungsmittel mit Lichtschutzwirkung
FR2746391B1 (fr) 1996-03-22 1998-04-17 Oreal Compositions cosmetiques a base de pyrazolin-4,5-diones, nouvelles pyrazolin-4,5 diones, procedes de preparation et utilisations
FR2761595B1 (fr) 1997-04-04 1999-09-17 Oreal Compositions comprenant des santalines, santarubines pour la coloration artificielle de la peau et utilisations
FR2768733B1 (fr) 1997-09-19 1999-10-29 Oreal Nouveaux composes 4,4-dihydroxypyrazolin-5-ones ; leurs procedes de preparation et utilisations cosmetiques
FR2780281B1 (fr) 1998-06-26 2000-08-18 Oreal Compositions comprenant des nanopigments d'oxydes de fer pour la coloration artificielle de la peau et utilisations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012158960A2 (en) 2011-05-17 2012-11-22 H. Lee Moffitt Cancer Center & Research Institute, Inc. Melanocortin 1 receptor ligands and methods of use
WO2014081845A2 (en) 2012-11-21 2014-05-30 University Of Cincinnati Skin care compositions and methods comprising selective agonists of melanocortin 1 receptor

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Jerry Ryan Holder et al.，Characterization of aliphatic, cyclic, and aromatic N-terminally "capped" His-D-Phe-Arg-Trp-NH2 tetrapeptides at the melanocortin receptors，European Journal of Pharmacology，2003年，Vol.462，pp.41-52
L. N. Koikov et al.，Sub-Nanomolar hMC1R Agonists by End-Capping of the Melanocortin Tetrapeptide His-D-Phe-Arg-Trp-NH2，Bioorg. Med. Chem. Lett.，2003年，Vol.13，pp.2647-2650

Also Published As

Publication number Publication date
EP3704134B1 (en) 2021-12-22
CN111278846A (zh) 2020-06-12
WO2019086361A1 (en) 2019-05-09
KR20200073278A (ko) 2020-06-23
CN111278846B (zh) 2023-10-27
US20200308222A1 (en) 2020-10-01
JP2021501133A (ja) 2021-01-14
EP3704134A1 (en) 2020-09-09
KR102694657B1 (ko) 2024-08-13
BR112020008175A2 (pt) 2020-10-20

Similar Documents

Publication Publication Date Title
US6616918B2 (en) Self-tanning composition containing an N-acyl amino acid ester and a self-tanning agent
JP7231307B2 (ja) 抗微生物性テトラペプチド
US11591367B2 (en) Melanocortin-1-receptor agonists
FR2854157A1 (fr) Derives de s-triazine possedant 3 groupements para-aminobenzalmalonates particuliers; compositions cosmetiques photoprotectrices contenant ces derives; utilisations desdits derives de s-triazine
WO2014177406A1 (en) Composition comprising at least three active agents for colouring and/or pigmenting keratin materials
KR102733924B1 (ko) Mmp-12 억제제로서 사용하기 위한 포스핀산 펩티드 유도체
CN109689676B (zh) 新型化合物
EP4262727A1 (en) Self-tanning compositions
EP3383881B1 (en) Phosphinic peptide derivatives for use as mmp-12 inhibitors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210506

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210506

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220419

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220606

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220916

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221014

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230117

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230210

R150 Certificate of patent or registration of utility model

Ref document number: 7231307

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150